Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Valganciclovir bulk supplier for pharma manufacturers

Valganciclovir Suppliers & Bulk Manufacturers

Available Forms: Tablet & Oral solution

Available Strengths: Tab: 450 mg; Oral solution: 50 mg/mL

Reference Brands: Valcyte®

Category: Anti Viral

Valganciclovir Tablets 450 mg are used to treat and prevent cytomegalovirus (CMV) infections in transplant and HIV patients. Available through PharmaB2B platforms from GMP-certified manufacturers, Valganciclovir offers high bioavailability and reliable antiviral action. Ideal for global buyers seeking quality bulk supply at competitive prices.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Valganciclovir Tablets are a potent antiviral used primarily to treat and prevent cytomegalovirus (CMV) infections, especially in immunocompromised patients, such as organ transplant recipients and individuals with HIV/AIDS. As a prodrug of ganciclovir, Valganciclovir offers improved oral bioavailability. Available in 450 mg strength, it is widely sourced by hospitals, pharmacies, and healthcare providers. On PharmaB2B platforms, buyers can connect with GMP-certified manufacturers and exporters for bulk supply of Valganciclovir Tablets. Ideal for global distributors seeking regulatory-compliant, high-quality products at competitive prices, PharmaB2B simplifies the procurement and sourcing of essential antiviral medications like Valganciclovir.

Valganciclovir — third party manufacturing & bulk supply

Valganciclovir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Valganciclovir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Valganciclovir →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Valganciclovir is used to prevent and treat cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those who have undergone organ transplants. It works by inhibiting viral DNA replication.

Valganciclovir is made from the antiviral prodrug valganciclovir hydrochloride, which is converted in the body to ganciclovir, the active agent that inhibits viral DNA polymerase.

The well-known trade name is Valcyte.

Valcyte is manufactured by Roche. Generic versions are also produced by multiple pharmaceutical companies worldwide.

The generic name is valganciclovir hydrochloride.

The primary brand name is Valcyte.

It is manufactured in approved facilities in the USA, Europe, and India, depending on whether it is the innovator brand or a generic version.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.